The founding of the Jiangsu Biopharmaceutical Industry Alliance and the conference on AI-empowered biopharmaceutical innovation were held in Nanjing. Guided by the Jiangsu Provincial Department of Industry and Information Technology and hosted by China Pharmaceutical University, with the Jiangning District People's Government, the Nanjing Municipal Bureau of Industry and Information Technology and the CPU Institute for Biopharmaceutical Strategy as co-organisers, the conference brought together government, industry, academia, research, healthcare and financial services to witness a milestone in the intelligent, high-end development of Jiangsu's biopharmaceutical industry.
As a leading local digital technology enterprise, Nanjing Linkage Digital Technology Co., Ltd. was invited to attend and signed a strategic cooperation agreement with China Pharmaceutical University on site. Focusing on building an intelligent ecosystem for original drug discovery, the partnership applies AI to upgrade the biopharmaceutical industry and injects digital momentum into Nanjing's ambition to become a nationally leading biopharmaceutical hub.
Industry Collaboration for High-Quality Biopharmaceutical Development in Nanjing
At the conference, the Jiangsu Biopharmaceutical Industry Alliance was officially unveiled, with 306 founding member organisations forming a collaborative system spanning government, industry, academia, research, healthcare and financial services.
Taking the alliance's founding as an opportunity, the conference established an important platform for industry exchange, project cooperation and technological breakthroughs. It will further amplify Nanjing's innovation resources in biopharmaceuticals, steadily advance the industry towards high-end, intelligent and clustered development, and inject strong momentum into Nanjing's drive to build a biopharmaceutical hub with national influence.
Linkage Digital Technology will use the alliance platform to extend its mature AI technology solutions across the industry and drive the overall intelligent upgrading of the regional biopharmaceutical sector.
Joining Forces on the Core Track of AI plus Biopharmaceuticals
At the conference, Linkage Digital Technology and China Pharmaceutical University signed a strategic cooperation agreement on the "AI Pharmaceutical Platform" project.
This cooperation is a key step in Linkage Digital Technology's AI plus biopharmaceutical strategy. Drawing on the company's core strengths in AI computing-power scheduling, intelligent algorithms and industrial-grade data governance, combined with CPU's top-tier research capability and industry resources in biopharmaceuticals, the two parties will rebuild the entire drug discovery chain through a fully intelligent, large-scale innovation model. The partnership will focus on breaking the efficiency bottlenecks of traditional drug discovery, deepen the integration of AI with pharmaceutical research scenarios, build an integrated "research-data-commercialisation" system, accelerate the development of original new drugs, and help the biopharmaceutical industry leap from "traditional R&D" to "intelligent R&D".
Going forward, Linkage Digital Technology will continue to deepen the integration of digital technology and biopharmaceuticals, keep iterating its AI technology and service offerings, and work with China Pharmaceutical University and industry partners to build an AI-empowered biopharmaceutical innovation ecosystem that contributes to industrial innovation.
